Clinical evaluation of a bacterially derived sodium hyaluronate 2.3% ophthalmic viscosurgical device

To compare the safety and effectiveness of bacterially derived and animal-derived sodium hyaluronate 2.3% ophthalmic viscosurgical devices (OVD) (Healon5 PRO and Healon5, respectively) in cataract surgery.

Source: Journal of Cataract and Refractive Surgery - August 8, 2019 Category: Opthalmology Authors: Daniel H. Chang, William C. Christie, James C. Loden, Pamela J. Smith, Beth E. Jackson Tags: Article Source Type: research